Venturi Wealth Management, LLC Dyne Therapeutics, Inc. Transaction History
Venturi Wealth Management, LLC
- $1.88 Billion
- Q4 2024
A detailed history of Venturi Wealth Management, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Venturi Wealth Management, LLC holds 270 shares of DYN stock, worth $3,909. This represents 0.0% of its overall portfolio holdings.
Number of Shares
270Holding current value
$3,909% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
210Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$116 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$107 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$99.4 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$98.7 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$98.7 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $750M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...